Assessment of Intratumoral Susceptibility Signals ( ITSS ) in Patients with newly diagnosed Glioblastoma using Quantitative Susceptibility Mapping ( QSM )

Journal article

A. Deistung, F. Schweser, S. Heiland, M. Bendszus, W. Wick, J. Reichenbach, A. Radbruch
2011

Cite

APA Click to copy
Deistung, A., Schweser, F., Heiland, S., Bendszus, M., Wick, W., Reichenbach, J., & Radbruch, A. (2011). Assessment of Intratumoral Susceptibility Signals ( ITSS ) in Patients with newly diagnosed Glioblastoma using Quantitative Susceptibility Mapping ( QSM ).

Chicago/Turabian Click to copy
Deistung, A., F. Schweser, S. Heiland, M. Bendszus, W. Wick, J. Reichenbach, and A. Radbruch. “Assessment of Intratumoral Susceptibility Signals ( ITSS ) in Patients with Newly Diagnosed Glioblastoma Using Quantitative Susceptibility Mapping ( QSM )” (2011).

MLA Click to copy
Deistung, A., et al. Assessment of Intratumoral Susceptibility Signals ( ITSS ) in Patients with Newly Diagnosed Glioblastoma Using Quantitative Susceptibility Mapping ( QSM ). 2011.

BibTeX Click to copy

@article{a2011a,
  title = {Assessment of Intratumoral Susceptibility Signals ( ITSS ) in Patients with newly diagnosed Glioblastoma using Quantitative Susceptibility Mapping ( QSM )},
  year = {2011},
  author = {Deistung, A. and Schweser, F. and Heiland, S. and Bendszus, M. and Wick, W. and Reichenbach, J. and Radbruch, A.}
}

Abstract

Susceptibility Mapping (QSM) Andreas Deistung, Ferdinand Schweser, Sabine Heiland, Martin Bendszus, Wolfgang Wick, Jürgen Rainer Reichenbach, and Alexander Radbruch Medical Physics Group, Department of Diagnostic and Interventional Radiology I, Jena University Hospital, Jena, Germany, Department of Neuroradiology, University of Heidelberg Medical Center, Heidelberg, Germany, Department of Neurooncology, University of Heidelberg Medical Center, Heidelberg, Germany